CNMD  Conmed Corporation

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

1.13B

Vuru Grade

37.57/100

Current Price

$40.51
+0.35 (+0.88%)

Growth Price

$31.77
Overvalued by 21.58%

Stability Price

$17.44
Overvalued by 56.94%

Company Metrics

  • P/E 65.44
  • P/S 1.53
  • P/B 1.94
  • EPS 0.62
  • Cash ROIC 6.92%
  • Cash Ratio 0.61
  • Dividend 0.80 / 2.01 %
  • Avg. Vol. 185,702.00
  • Shares 27.89M
  • Market Cap. 1.13B

Company Description

CONMED Corporation, a medical technology company, provides surgical devices and equipment for minimally invasive procedures and monitoring. The company's products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery, and endoscopic technologies. It offers arthroscopy products, including powered resection instruments, art... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

CONMED Corporation Announces Second Quarter 2016 Financial Results
Business Wire (press release) - Jul 27, 2016
CONMED has a direct selling presence in 17 countries, and international sales constitute approximately 50% of the Company's total sales.
CONMED Corporation Announces Fourth Quarter and Fiscal Year 2015 Financial Results
Business Wire (press release) - Jan 27, 2016
In addition, gross margin improvement in the second half of the year and lower operating expenses as a result of cost saving initiatives are positive trends we intend to build on entering 2016,” commented Curt R. Hartman, CONMED's President and Chief ...
KeyBanc Comments on CONMED Co.'s FY2016 Earnings (CNMD) - EMQ
CONMED Corporation Announces First Quarter 2016 Financial Results
Business Wire (press release) - Apr 27, 2016
Further, the contribution from the AirSeal® System was in line with our expectations,” commented Curt R. Hartman, CONMED's President and Chief Executive Officer. “Despite a slow start to the year for capital sales in the international markets, we saw ...
CONMED Corporation Adds Health Care Executive Martha Goldberg Aronson to its ...
Business Wire (press release) - Feb 23, 2016
“We are pleased to welcome Martha to our Board of Directors,” commented Mark Tryniski, Chairman of CONMED's Board of Directors.
Conmed Corp. (CNMD) Upgraded at Zacks Investment Research
BBNS - Sep 27, 2016
Conmed Corp. (NASDAQ:CNMD) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Tuesday.
Keeping an Eye on This Dividend Stock With Upside Potential: CONMED ... - Post News
Latest Analyst Reports On CONMED Corporation - NewsDen
CONMED Corporation to Present at the Annual J.P. Morgan Healthcare Conference
Business Wire (press release) - Dec 17, 2015
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the 34th Annual J.P.
CONMED Corporation to Announce Second Quarter 2016 Financial Results on July ...
Business Wire (press release) - Jul 7, 2016
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the second quarter of fiscal year 2016 after the market close on Wednesday, July 27, 2016.
CONMED Corporation to Announce First Quarter 2016 Financial Results on April ...
Business Wire (press release) - Apr 6, 2016
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the first quarter of fiscal year 2016 after the market close on Wednesday, April 27, 2016.
CONMED Corporation Announces Annual Meeting of Shareholders
Business Wire (press release) - Mar 7, 2016
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that its Annual Meeting of Shareholders will be held at the Company's corporate offices, 525 French Road, Utica, NY on Wednesday, May 25, 2016, at 2:30 p.m.
CONMED's Renewed Quest For Growth
Seeking Alpha - Apr 8, 2016
Turnaround stories can pay handsomely in the med-tech space, and CONMED (NASDAQ:CNMD) has certainly been doing a lot of the right things since activist investors catalyzed a major shake-up in 2014.